August 22, 2019 Astra could use a voucher to cement roxadustat’s head start Spending $95m to speed up the anaemia project’s path to approval could be worth the investment for Astrazeneca.
August 31, 2018 Working for the government proves extremely profitable for Emergent With its latest acquisition Emergent Biosolutions is tapping into new ways to access public spending.
